07.08.2023 - NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) - Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and developing transformative therapeutics for patients, announces the appointment of Roger Waltzman, M.D. as its . Seite 1